IT8468281A1 - Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche. - Google Patents

Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.

Info

Publication number
IT8468281A1
IT8468281A1 IT1984A68281A IT6828184A IT8468281A1 IT 8468281 A1 IT8468281 A1 IT 8468281A1 IT 1984A68281 A IT1984A68281 A IT 1984A68281A IT 6828184 A IT6828184 A IT 6828184A IT 8468281 A1 IT8468281 A1 IT 8468281A1
Authority
IT
Italy
Prior art keywords
proglumide
therapy
pharmaceutical compositions
compositions containing
neoplastic diseases
Prior art date
Application number
IT1984A68281A
Other languages
English (en)
Other versions
IT8468281A0 (it
IT1179894B (it
Original Assignee
Rotta Res Laboratorium S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Res Laboratorium S P A filed Critical Rotta Res Laboratorium S P A
Priority to IT68281/84A priority Critical patent/IT1179894B/it
Publication of IT8468281A0 publication Critical patent/IT8468281A0/it
Priority to JP61500356A priority patent/JPH0667832B2/ja
Priority to US06/900,152 priority patent/US4978683A/en
Priority to PCT/EP1985/000673 priority patent/WO1986003968A1/en
Priority to EP86900107A priority patent/EP0235151B1/en
Priority to DE8686900107T priority patent/DE3582594D1/de
Publication of IT8468281A1 publication Critical patent/IT8468281A1/it
Application granted granted Critical
Publication of IT1179894B publication Critical patent/IT1179894B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT68281/84A 1984-12-27 1984-12-27 Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche IT1179894B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT68281/84A IT1179894B (it) 1984-12-27 1984-12-27 Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche
JP61500356A JPH0667832B2 (ja) 1984-12-27 1985-12-05 腫瘍性疾患の治療に用いるプログルミド含有医薬組成物
US06/900,152 US4978683A (en) 1984-12-27 1985-12-05 Proglumide and pharmaceutical compositions containing it for use in the treatment of neoplastic affections
PCT/EP1985/000673 WO1986003968A1 (en) 1984-12-27 1985-12-05 Proglumide and pharmaceutical compositions containing it for use in the treatment of neoplastic affections
EP86900107A EP0235151B1 (en) 1984-12-27 1985-12-05 Proglumide and pharmaceutical compositions containing it for use in the treatment of neoplastic affections
DE8686900107T DE3582594D1 (de) 1984-12-27 1985-12-05 Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT68281/84A IT1179894B (it) 1984-12-27 1984-12-27 Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche

Publications (3)

Publication Number Publication Date
IT8468281A0 IT8468281A0 (it) 1984-12-27
IT8468281A1 true IT8468281A1 (it) 1986-06-27
IT1179894B IT1179894B (it) 1987-09-16

Family

ID=11308819

Family Applications (1)

Application Number Title Priority Date Filing Date
IT68281/84A IT1179894B (it) 1984-12-27 1984-12-27 Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche

Country Status (6)

Country Link
US (1) US4978683A (it)
EP (1) EP0235151B1 (it)
JP (1) JPH0667832B2 (it)
DE (1) DE3582594D1 (it)
IT (1) IT1179894B (it)
WO (1) WO1986003968A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880938A (en) * 1986-06-16 1989-11-14 Merck & Co., Inc. Amino acid analogs
US5089638A (en) * 1986-06-16 1992-02-18 Merck & Co., Inc. Amino acid analogs as CCK-antagonists
SE8901149D0 (sv) * 1989-04-03 1989-04-03 Pharmacia Ab Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
DK0889735T3 (da) * 1996-02-08 2011-08-08 Cancer Advances Inc Immunogene metoder til behandling af gastrointestinal cancer
JP2002515458A (ja) * 1998-05-15 2002-05-28 アフトン・コーポレーシヨン 高ガストリン血症の予防および処置
CA2441228A1 (en) 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
JP2004536835A (ja) * 2001-07-09 2004-12-09 アフトン コーポレーション 肝臓、肺および食道の癌性ならびに前癌性状態の治療および防止
US7235376B2 (en) * 2003-03-28 2007-06-26 Receptor Biologix, Inc. Gastrin hormone immunoassays
WO2005011665A1 (en) * 2003-07-22 2005-02-10 Arakis Ltd. The use of proglumide for the treatment of emesis
EP2567974A3 (en) 2004-09-22 2013-05-22 Cancer Advances, Inc., Monoclonal antibodies to progastrin
GB2516436A (en) * 2013-07-20 2015-01-28 Pornthip Lattmann Benzydamine, an anti-neoplastic agent, acting as cholecystokinin antagonist Gl and brain cancers
IL271427B2 (en) 2017-06-15 2025-08-01 Cancer Advances Inc Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer

Also Published As

Publication number Publication date
JPH0667832B2 (ja) 1994-08-31
JPS62501705A (ja) 1987-07-09
WO1986003968A1 (en) 1986-07-17
IT8468281A0 (it) 1984-12-27
EP0235151A1 (en) 1987-09-09
IT1179894B (it) 1987-09-16
US4978683A (en) 1990-12-18
EP0235151B1 (en) 1991-04-17
DE3582594D1 (de) 1991-05-23

Similar Documents

Publication Publication Date Title
IT8467445A1 (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea.
ITRM940328A0 (it) "uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario".-
IT8468281A0 (it) Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
IT1206452B (it) Ammidine ad attivita' farmaceutica e relativo procedimento di fabbricazione.
EP0163582A3 (en) Medicines which improve the free-flowing properties of blood, and their therapeutical use
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
IT1191893B (it) Sistema di supporto dentario e procedimento per l'impiego nella formazione e ritenzione di un restauro dentario
IT1213141B (it) Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche.
IT8521322A0 (it) Composti e composizioni farmaceutiche per la terapia di retinopatie e neuropatie diabetiche.
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
DE3277171D1 (en) Pharmaceutical composition and the use of sn- or cr-protoporphyrin for the manufacture thereof
IT1170238B (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
IT7824578A0 (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza.
EG14024A (en) Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases
IT1134202B (it) Coadiuvante per promuovere l'absorbimento di sostanze farmacologicamente attive attraverso il retto,e composizione farmaceutica che lo comprendono
FI834429A7 (fi) 3',5'-diarabinosidien valmistus ja terapeuttinen soveltaminen.
IT8422685A0 (it) Composizione farmaceutica eprocedimento per il trattamento di eccetazione psicomotoria.
IT8322370A0 (it) Applicazione terapeutica delmazindolo nella malattia di parkinson.
IT1282951B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento dell'insonnia
IT8421996A0 (it) Preparazioni farmaceutiche ad azione protratta attive nel trattamento di riniti e di altre affezioni nasali.
IT1221738B (it) Veicoli per l'erogazione prolungata di trinitroglicerian e preparati relativi
IT9022513A0 (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19931130